Opioid Prescription Verification Act of 2021

Bill: 117-hr-2355
Sponsor: Rep. Davis, Rodney [R-IL-13]
Introduced: 2021-04-05 in the House
Policy area: Health
Subjects: Business records
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government information and archives
Health information and medical records
Health personnel
Health programs administration and funding
Photography and imaging
Prescription drugs
Retail and wholesale trades

Summary:
action_date: 2021-04-05
text: 

Opioid Prescription Verification Act of 2021

 
This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).
 
Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of individuals who pick up prescribed medications.
 
In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that
 
 
maintain a prescription drug monitoring program that mandates the collection of specified information, and 
 
require dispensers of certain potentially addictive drugs to verify the identity of individuals who pick up prescribed medications. 
 

action_date: 2021-11-30
text: 

Opioid Prescription Verification Act of 2021

 
This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).
 
Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of patients who are prescribed medications.
 
In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that
 
 
maintain a prescription drug monitoring program that mandates the collection of specified information,
 
require prescribers of certain potentially addictive medications to issue prescriptions electronically (subject to some exceptions), and
 
require dispensers of certain potentially addictive medications to enter particular information about the purchase of such medications into their state's prescription drug monitoring program.
 

action_date: 2021-12-08
text: 

Opioid Prescription Verification Act of 2021

 
This bill modifies overdose prevention activities carried out by the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC).
 
Specifically, HHS must update pharmacist training materials to include information about how to verify the identity of patients who are prescribed medications.
 
In addition, the CDC may give preference, in awarding grants for overdose prevention, to states that
 
 
maintain a prescription drug monitoring program that mandates the collection of specified information,
 
require prescribers of certain potentially addictive medications to issue prescriptions electronically (subject to some exceptions), and
 
require dispensers of certain potentially addictive medications to enter particular information about the purchase of such medications into their state's prescription drug monitoring program.
 


Legislative actions:
action_date: 2021-12-09
text: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
action_date: 2021-12-08
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2021-12-08
text: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422). (consideration: CR H7540-7541)
action_date: 2021-12-08
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 410 - 15 (Roll no. 422).(consideration: CR H7540-7541)
action_date: 2021-11-30
text: At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
action_date: 2021-11-30
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 2355.
action_date: 2021-11-30
text: Considered under suspension of the rules. (consideration: CR H6691-6693; text: CR H6691)
action_date: 2021-11-30
text: Mr. Pallone moved to suspend the rules and pass the bill, as amended.
action_date: 2021-11-30
text: Placed on the Union Calendar, Calendar No. 130.
action_date: 2021-11-30
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.
action_date: 2021-11-30
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-180.
action_date: 2021-07-21
text: Ordered to be Reported (Amended) by Voice Vote.
action_date: 2021-07-21
text: Committee Consideration and Mark-up Session Held.
action_date: 2021-07-15
text: Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
action_date: 2021-07-15
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2021-04-13
text: Referred to the Subcommittee on Health.
action_date: 2021-04-05
text: Referred to the House Committee on Energy and Commerce.
action_date: 2021-04-05
text: Introduced in House
action_date: 2021-04-05
text: Introduced in House